| Date Filed | Type | Description |
| 07/07/2023 |
4
| Barlow Jane F (Director) has filed a Form 4 on SERA PROGNOSTICS, INC.|
Txns:
| Granted 63,265 options to buy
@ $3, valued at
$189.8k
|
|
| 06/09/2023 |
4
| Barlow Jane F (Director) has filed a Form 4 on Viracta Therapeutics, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.5, valued at
$60k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2022 |
4
| Barlow Jane F (Director) has filed a Form 4 on SERA PROGNOSTICS, INC.|
Txns:
| Granted 140,823 options to buy
@ $2.83, valued at
$398.5k
|
|
| 04/12/2022 |
3
| Barlow Jane F (Director) has filed a Form 3 on SERA PROGNOSTICS, INC. |
| 02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Barlow Jane F (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $38.09, valued at
$952.3k
|
|
| 12/13/2019 |
4
| Barlow Jane F (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Granted 50,000 options to buy
@ $15.71, valued at
$785.5k
|
|
| 12/13/2019 |
3
| Barlow Jane F (Director) has filed a Form 3 on MOMENTA PHARMACEUTICALS INC |
| 08/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2018 |
4
| Barlow Jane F (Director) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 50,000 options to buy
@ $6.35, valued at
$317.5k
|
|
| 04/18/2018 |
4
| Barlow Jane F (Director) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 50,000 options to buy
@ $5.72, valued at
$286k
|
|
| 04/05/2018 |
3
| Barlow Jane F (Director) has filed a Form 3 on TherapeuticsMD, Inc. |